ReviewThe Lancet regional health. Europe2026
Strengthening non-communicable diseases monitoring systems in Europe through a multistakeholder collaborative approach: a key priority for advancing data-driven policymaking.
Review in The Lancet regional health. Europe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Disability inclusion as a missing pillar of Africa's non-communicable disease response.BMJ global health · 2026Article
- A Comparative Analysis of National Health Strategies and Policy Documents in Selected Latin American and African Countries.International journal of environmental research and public health · 2026Review
- Closing the implementation gap: the Joint Action on Cardiovascular Diseases and Diabetes (JACARDI) as a proof of-concept for Europe's Safe Hearts Plan.International journal of public health · 2026Article
- From commitment to capacity: strengthening Europe's public health response to cardiovascular disease and diabetes through life-course prevention.Public health reviews · 2026Article
- Implementing a federated regional diabetes register in a decentralized health system: implications for healthcare organization and the European Health Data Space.Frontiers in public health · 2026Article
- Infrastructure of tobacco and nicotine cessation services in Finnish healthcare: A cross-sectional study.Tobacco induced diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
Abstract
Non-communicable diseases (NCDs) are major drivers of disability, health expenditure, and productivity loss in Europe. Effective surveillance is essential to understand evolving needs, design and evaluate interventions, and ensure accountability. This paper provides a high-level overview of NCD monitoring in Europe, focusing on cardiovascular diseases, cancer, diabetes, chronic respiratory diseases, and major modifiable risk factors. It draws on three complementary sources: the EU Joint Action on Cardiovascular Diseases and Diabetes (JACARDI, 32 countries), the Joint Action on the Prevention of NCDs (JA PreventNCD, 16 countries), and the WHO NCD Country Capacity Survey (2023, 53 WHO European Region Member States). These sources provide a comprehensive assessment of surveillance capacity, infrastructure and gaps, showing that NCD monitoring remains fragmented, underfunded, and limited in equity-sensitive data and policy integration. Strengthening governance, investment, and cross-country collaboration is crucial to build interoperable, and equity-oriented systems supporting evidence-informed decisions, accountability, and the right to health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.